10^th International Conference on Infectious Diseases, Bacteriology and Antibiotics May 24-25, 2023 Paris, France

Track-1 Infectious Diseases

Outbreaks of human infectious diseases worldwide span decades. They are major public health problems around the world, killing more people worldwide than any other cause and having a greater impact on the developing world. Increased development and global homogeneity due to social and environmental changes due to travel, increased trade, and globalization increase the risk of infectious diseases. An infectious disease is a disease caused by bacteria (bacteria, viruses, fungi, etc.) entering the body and multiplying to cause an infection. Some infections are contagious and some are not.

Infections can be transmitted by bacteria in the air, water, food, or soil. They can also be spread by vectors, bacteria, viruses, or animals.

·         Bone and joint infections

·         Fever of unknown cause

·         HIV/AIDS

·         Infectious mononucleosis

·         Lyme disease

·         Meningitis

·         MRSA (methicillin-resistant Staphylococcus aureus)

·         Respiratory syncytial virus (RSV)

·         Staphylococcal infection

Track-2 Immunology of Infections

The immunology of infectious diseases involves the battle between pathogens and the host's immune system. Immunology is a branch of science that deals with various aspects of the immune system, including innate and adaptive immunity. Immunology also deals with experimental techniques in which antigens interact with specific antibodies.

Track-3 Treatment for Infectious Diseases

Treatment of viral infections such as HIV involves patient care and moral support, including antiretroviral therapy. Bacterial infections can be treated by giving the patient antibiotics. Yeast infections can be treated primarily with sterile techniques. Parasitic infections can be treated with antiparasitic drugs. Diseases such as cancer can be treated with chemotherapy. Modern technology proves that there is no disease that cannot be cured.

Track-4 Lyme disease

Lyme disease is caused by a bacterium known as Borrelia burgdorferi. Humans are infected by being bitten by an infected blackleg tick. Typical symptoms are fever, fatigue, headache, and a characteristic skin rash called erythema migrans. If left untreated, the infection can spread to the joints, heart, and nervous system. The disease is treated based on symptoms, physical findings (such as a rash), and possible exposure to infected ticks. Laboratory tests are helpful when used correctly and performed using validated methods. Most cases of Lyme disease can be successfully treated with a few weeks of antibiotics. Measures to prevent Lyme disease include the use of insecticides, and repellents, prompt removal of ticks, and reduction of tick habitat.

·         Current Efforts in Lyme Disease Research

·         Etiology Studies

·         Vector Studies

·         Infection Persistence Studies

·         Lyme Disease Diagnosis Studies

·         Lyme Disease Vaccine Studies

·         Clinical Studies

Track-5 Fifth Disease

The fifth disease is a mild rash infection with parvovirus B19. This disease is also known as erythema infectious. It is more common in children than in adults. A person usually develops the fifth disease within 4 to 14 days after a person is infected with parvovirus B19. The main symptoms of the fifth disease are usually mild and include fever, runny nose, and headache. The disease is contagious because the rash is due to an immune system reaction that occurs after the infection has passed. Anyone who has the fifth disease before the rash appears is most contagious. Children usually do not spread the infection when they have the rash. The disease is caused by a virus and cannot be treated with antibiotics. In most cases, it is a mild illness that goes away on its own and does not require medication.

·         Human Parvovirus

·         Diagnosis and Treatment

·         Fifth Disease and Pregnancy

Track-6 Autoimmune Disease

Autoimmune diseases affect 50 million people worldwide. In the United States, it is one of the top ten causes of death for women under the age of 65, the second leading cause of chronic disease, and the leading morbidity among women. These diseases are the result of a malfunction of the immune system. The immune system protects a person from infections and diseases. The immune system can produce autoantibodies that attack healthy cells, tissues, and organs. This can lead to autoimmune diseases. It can affect any part of the body. Well-known autoimmune diseases include type 1 diabetes, multiple sclerosis, lupus and rheumatoid arthritis, and celiac disease, but others are rare and difficult to diagnose. There are life-threatening autoimmune diseases, most of which weaken the human immune system and require lifelong treatment. Although treatments exist to reduce the symptoms and effects of many autoimmune diseases, no cure has yet been discovered. Because most autoimmune diseases are rare, patients spend years searching for a proper diagnosis.

·         Variety of Autoimmune Diseases

·         Autoimmune Responses.

·         Cancer

·         Celiac Disease

·         Clinical Trials

·         Translational Research

·         Lupus

·         Multiple Sclerosis

·         Rheumatoid Arthritis

Track-7 H5N1 Influenza

H5N1 infections can cause severe illness in humans and are associated with high mortality. This is the world's most prevalent bird flu, influenza. Causes symptomatic and asymptomatic infections in many vertebrate species, including ducks, geese, terns, chickens, quail, turkeys, pheasants, starlings, budgerigars, gibbons, baboons, chimpanzees, and humans I'm here. In many cases, bird flu in humans develops into a serious illness that requires timely treatment in the hospital and may require intensive care. We recommend that anyone working in the poultry industry follow biosecurity and infection control practices. This includes using proper personal protective equipment and paying close attention to hygiene. The antiviral drug oseltamivir can reduce the severity of the illness and prevent death. You should use it anyway.

·         Antivirals

·         Seasonal Influenza

·         Pandemic Influenza and its Control

·         Avoiding Sources of Exposure

·         Biosecurity

·         Infection Control Practices

Track-8 Infection, Immunity & Inflammation

This infection is spread by the Aedas mosquito. These infections can cause baby miscarriage in spoiled pregnant women, and side effects include low-grade fevers, rashes, conjunctivitis, muscle and joint pain, restlessness, or migraines. These are 2-7. Lasts for days. This contamination has been verified by laboratory testing using blood or other bodily fluids. B. Urine, saliva, or semen was identified. Ebola disease (EVD), commonly called Ebola hemorrhagic fever (EHF) or Ebola, is usually accompanied by fever, sore throat, and severe pain between two days and three weeks after infection, at which point migraines, nausea, and running. Symptoms such as running. A rash is common and the liver and kidneys are weakened.

·         Molecular Pathogenesis

·         Cell Microbiology

·         Virulence Factors

·         Host Resistance

Track-9 Emerging and Re-Emerging Infectious Diseases & Their Impact

The feasibility of disease control depends on a large number of emerging and re-emerging pathogens, the diversity of geographic sources, the potential for rapid global spread from these sources, and a large number of environmental and It can be hindered by social factors.

A disease is an emerging disease only if it is an entirely new infectious disease or has recently increased in impact and severity and is affecting new parts of the world. A re-emerging disease is one that was once known to be a major health problem but has receded and is now a public health problem again.

·         Acanthamebiasis

·         Australian bat lyssavirus

·         Bayesian, atypical

·         Bartonella henselae

·         Coronaviruses, including SARS coronavirus

·         Ehrlichiosis

·         Encephalitozoon cuniculi

·         Encephalitozoon hellem

·         Enterocytozoon bieneusi

·         Helicobacter pylori

·         Hendra virus (equine morbillivirus)

·         Hepatitis C

·         MRSA Infection

·         Hepatitis E

·         Coccidioides immitis

·         Enterovirus 71

·         Prion disease streptococcus Group A

·         H5N1 Influenza

·         Staphylococcus aureus

Track-10 Zika Virus

Zika virus is a single-stranded RNA flavivirus that is a member of the Flaviviridae family. The virus is genetically related to several other viruses that cause human encephalitis, including the chikungunya virus, dengue virus, West Nile virus, and yellow fever virus. It is one of the arboviruses transmitted by Aedes aegypti. The main vectors are Aedes aegypti and Aedes aegypti. It causes severe hemorrhagic fever with high mortality in humans. When the virus spreads throughout the body, it damages the immune system and organs. Eventually, the level of blood clotting cells will decrease. This results in massive, uncontrolled bleeding.

·         Treatment Strategies

·         Clinical Symptoms

·         Vaccine Development

·         Challenges in Zika Virus Treatment

Track-11 Ebola Virus

Recent Ebola virus disease outbreaks in both developing and developed countries have reminded us of the enormous threat posed by emerging infectious diseases. The Ebola virus is highly contagious after early symptoms appear. Infected patients shed infectious viruses in all body secretions or fluids. The virus can be transmitted when a person has direct contact with any of these secretions. Infection is spread through direct contact with blood, secretions, or anything left on clothing, and through equipment used to treat patients. Ebola is still not cured. Drugs such as ZMapp and TKM-Ebola are used for treatment. Professionals prescribe drugs such as acetaminophen (Tylenol) to reduce fever and pain. Treatment includes experimental sera that destroy infected cells.

·         Paracetamol

·         ZMapp and TKM-Ebola

·         Ebola virus epidemiology

Track-12 Pediatric Infectious Diseases

Children are more vulnerable to environmental hazards than adults for a variety of reasons. Children are constantly growing, so they eat more food, drink more water, and breathe more air than adults. They are more susceptible to disease. These epidemics are mainly caused by microscopic organisms, infections, and parasites. A wide variety of immune diseases are caused by microorganisms, infections, pathogens, bacteria, and parasites. A pediatrician can understand the symptoms, signs, causes, side effects, medications, and consequences associated with infections in children.

·         Chicken Pox

·         Conjunctivitis

·         Gastroenteritis

·         German measles (Rubella)

·         Glandular Fever

·         Hand Foot and Mouth Disease

·         Head Lice

·         Hepatitis A

·         Impetigo (school sores)

·         Influenza

·         Measles

·         Meningococcal Disease

·         Molluscum Contagiosum

·         Mumps

·         Scabies

·         Scarlet Fever

·         Whooping Cough

Track-13 Respiratory Tract and Pulmonary Infectious Diseases

A normal person normally takes about 25,000 breaths. The term respiratory disease refers to many conditions that affect the lungs, such as asthma, COPD, influenza, pneumonia, infections such as tuberculosis, lung cancer, and many other respiratory problems. Several lung diseases can cause respiratory failure, some of which are contagious and others not. A hallmark of various respiratory infections is structural and functional changes in which inflammation is localized. depends greatly on the degree of infection of the nasopharynx thus causing nasal discharge, cough and phlegm bronchitis, cough, and phlegm pneumonia, but also increases respiratory rate and chest X-ray changes. Most upper respiratory tract infections are caused by viruses and resolve on their own.

·         Pneumonia

·         Influenza

·         Pharyngitis

·         Acute sinusitis

·         Laryngitis

·         Empyema

Track-14 Infectious Diseases Epidemiology

The epidemiology of an infectious disease or epidemic includes the study of prevalence, incidence, and factors of infection in a population. They remain one of the leading causes of morbidity and mortality worldwide.

·         Epidemiology of Emerging and Reemerging Infectious Diseases

·         Development of Vaccines and Other Preventive Methods

·         Clinical Studies

·         Role of Infectious Agents in Pathogenesis

Track-15 Blood Infectious Diseases

Many pathogens and pathogens are transmitted through blood and cause infections. Injection of blood or its components into the body, transfusion, introduces much greater amounts of infectious agents into blood vessels than accidental needle sticks. Blood-borne pathogens include hepatitis virus, syphilitic spirochete, and retroviruses such as adult T-cell leukemia virus and AIDS virus.

·         Sepsis

·         Dengue Fever

·         Human Immunodeficiency Virus (HIV)

·         Hepatitis A, B, and C

Track-16 Diseases of Reproductive Organs and Sexually Transmitted Diseases

STDs are a type of infection of the reproductive organs. They are also known as sexually transmitted diseases or genital diseases. Endogenous and iatrogenic infections are other types of genital infections. Endogenous infections are usually caused by an overgrowth of organisms normally present in the reproductive tract. An example of an endogenous infection is bacterial vaginosis. Other reproductive diseases include syphilis, herpes simplex virus (HSV), ulcerative mole, lymphogranuloma (LGV), human papillomavirus infection (HPV), and chlamydia/gonococci. Although there is currently no cure for viral sexually transmitted infections, treatment can relieve some of the symptoms and lessen the severity of some of the consequences.

·         Endogenous infections

·         Iatrogenic infections

·         Bacterial vaginosis

·         Syphilis

·         Herpes simplex virus (HSV)

·         Soft ulcers

·         Lymphogranuloma (LGV)

·         Human papillomavirus infection (HPV)

·         Chlamydia/Gonorrhea

·         Human Trichomonas virus Four

Track-17 Viral Hepatitis

Viral hepatitis is a global public health problem that affects millions of people worldwide each year, causing disability and death. Appropriate measures such as vaccination, safe injections, a safe diet, and a safe blood supply can reduce the rate of transmission of viral hepatitis. Many of these measures not only reduce the transmission of viral hepatitis but also affect the prevention of various other communicable diseases. Additionally, current treatments for hepatitis B and C provide healthcare providers with powerful tools to combat the disease. New advanced antiretroviral drugs such as TDF, 3TC, and FTC are effective in treating HIV and HBV infections. Co-infection therapy for hepatitis B and hepatitis C is also being developed, and the future looks brighter than ever. d The patient can take fewer medications to treat these two conditions for her. Viral hepatitis can also be prevented by timely vaccination and good hygiene.

·         Screening Tests

·         Antiretrovirals

·         Safe Injection Practices

·         Blood Safety Strategies

·         Assessment and Management of Chronically Infected Persons

·         Personal and Community Health

·         Antivirals Such as Lamivudine and Adefovir

·         Pegylated Interferon Injections

Track-18 Global Eradication of Diseases

There is a famous saying. This is true when it comes to global infection control or global disease eradication. The most common debate among public health professionals is how to leverage existing medical technology to reduce the incidence and prevalence of infectious diseases. To date, only smallpox has been eradicated by the vaccine, saving nearly 5 million lives annually. Regular application of personal and community hygiene, public health, environmental change, vaccines, and vector control have interrupted the transmission of disease-causing organisms such as cholera, yellow fever, and malaria in many countries. I hope that technological advances will one day help eradicate infectious diseases around the world.

Track-19 Neurological Infectious Disease

Despite remarkable advances in the treatment of infectious diseases, the "CNS" of the central nervous system is not functioning normally. Infectious diseases remain a major challenge. Diagnosis is often difficult and treatment is inadequate or non-existent. Infections can be classified as acute or chronic. Nervous system infections may involve the meninges (meningitis) or the brain itself (encephalitis) or both (meningoencephalitis). Some infections either cause neurological damage themselves or provoke an inflammatory response at the same time as the infection. Some inflammatory diseases can introduce new problems that may be related to the disease. These differences are fundamental as management and outcomes may be affected by the timely initiation of treatment.

·         Tuscan virus infection

·         Meningitis

·         Encephalitis

·         Polyleukoencephalopathy

·         Neurosarcoidosis

·         Transversal myelitis

·         Hydrocephalus

·         Parameningitis

Track-20 MRSA

MRSA is now the pathogen of a global health problem. These are Staphylococcus aureus strains that are resistant to oxacillin, nafcillin, and methicillin. They are also resistant to all beta-lactam drugs. It can cause a variety of problems, from skin infections and sepsis to pneumonia and various types of bloodstream infections. It is commonly seen in people in medical facilities such as dialysis centers. The current arsenal of antibiotics available for the treatment of MRSA includes topical agents and a limited number of oral agents.

·         Community-acquired MRSA (CA-MRSA)

·         Healthcare-associated MRSA (HA-MRSA)

·         CA-MRSA virulence-related factors

·         Antibiotic-resistant linezolid

·         Pneumonia (HAP/VAP)

·         Chronic osteomyelitis (COM)

·         Skin and soft tissue infections

Track-21 Pandemic and epidemic diseases

A massive pandemic could kill millions and cost trillions of dollars. A pandemic is an infectious disease that spreads around the world and causes serious death. A disease is considered endemic when the number of cases in a region exceeds what would normally be expected. Infectious diseases have posed a constant threat to human health throughout history. Epidemics still threaten people because most epidemics have epidemic origins, but changes in behavioral patterns have resulted in epidemic rates for some chronic diseases. There are countless outbreaks of serious infectious diseases around the world. Some diseases are expected to cause serious epidemics. These include Ebola, Crimean-Congo, Lassa, Rift Valley, Chikungunya, Zika, Marburg, and SARS.

·         Common source outbreak

·         Propagated outbreak

·         Asian flu

·         Swine Flu

·         Lassa fever

·         Rift Valley fever

·         SARS

·         Crimean-Congo hemorrhagic fever

Track-22 Vaccination and Infectious diseases

Vaccination has made a significant contribution to global health. This is a very effective way of preventing certain infections. Vaccines are generally very safe with few serious side effects or side effects. There are many types of vaccines that help develop immunity by mimicking infection. Two major infectious diseases, smallpox, and rinderpest have been eradicated with the help of these vaccines, but diseases such as viral hepatitis, influenza, and tuberculosis (TB) remain major ailments and deaths worldwide. One of the causes. Diseases for which vaccines are available are measles, rubella, cholera, meningococcal disease, poliomyelitis, chickenpox, and herpes zoster (shingles).

·         Live Attenuated Vaccine

·         Inactivated Vaccine

·         Toxoid Vaccine

·         Conjugate Vaccine

·         Subunit Vaccine

Track-23 Veterinary Infectious Diseases

In veterinary hospitals, it is important to control infectious and parasitic diseases. The main purpose is to prevent the spread of infectious diseases and pests. Veterinary infections are caused by bacteria, fungi, viruses, and parasites. These infections and diseases can spread and be transmitted from person to person, person to animal, and animal to person.

Track-24 Rheumatic Heart Disease

Rheumatic heart disease is a complication of rheumatic fever that damages heart valves. Rheumatic fever is an inflammatory disease that causes a sore throat. It damages connective tissue throughout the body, mainly in the heart, joints, brain, and skin. The best way to prevent rheumatic fever is to treat a sore throat with antibiotics. Treatment for this disease includes antibiotic treatment for streptococcal infections and additional medications to reduce heart inflammation and other symptoms. Aspirin is usually given in high doses until the joint inflammation subsides. After the acute illness subsides, patients must take antibiotics for years to prevent a recurrence. This is a very important treatment because recurrences of rheumatic fever increase the risk of heart valve damage.

·         Diagnosis

·         Echocardiography

·         Antibiotic Prophylaxis

·         Surgical Repair or Replacement of Damaged Heart Valves

·         Genetic Susceptibility

• Imperial College London
• Swedish Institute for Infectious Disease Control
• Columbia University
• University of Gothenburg
• University of Oslo
• University of Otago
• University of Pittsburgh
• Emory Health Sciences
• Uppsala University
• University of Liverpool
• University of Colorado Denver
• Queensland University of Technology
• Infectious Diseases Society of America
• Georgia Medical College

PRESENTATION REQUIREMENTS:

• Registration fees, transportation expenses, and accommodation expenses are the responsibility of the presenter. Note: If your abstract is approved, you will receive an approval email to register for the conference.
• Abstracts will be compiled and conference books will be made available to conference attendees.
• If the presenter is unable to attend, arrangements must be made for another qualified person to present the paper/poster in question. Please let the conference team know if such changes are required

SUBMISSION OPTIONS:

• Oral presentations have 30-minute time slots and are grouped into sessions by topic. The keynote speech is 45 minutes, the workshop/special session is 60 minutes, the symposium is 60 minutes, and the question and answer session is 5 minutes.
• Ph.D. and Master's students are eligible to submit abstracts in the Poster and E-Poster presentation categories.
• Ph.D. students are eligible to submit abstracts in a special category of the (Young Researcher's Forum), poster, and electronic poster presentations. Note: The YRF category includes short oral presentations specifically for Ph.D. Student
• Extended Abstract: Submissions must use the Abstract Template. Papers submitted to this category may constitute original empirical research, theoretical developments, reviews, or critiques.

Oral presentation: Oral presentations can include topics from research, theory, and professional or personal practice in a concise format. Those with personal experience are also welcome to present personal experiences and stories that help others in their daily lives. Should be allotted 40-45 minutes and the remaining time should be devoted to questions and discussion by the session chair.

Workshop: Even for workshop facilitators, the lecture topics are the same as the oral presentations with more professional techniques and detailed demonstrations. Workshop presentations typically last approximately 45-50 minutes. Interested participants can team up with their respective teams and present the workshop with the research coordinator with a special group exemption upon registration.

Poster presentation: The Infectious Diseases-2023 conference will host a student poster competition to encourage students and recent graduates to present their own research. Presenters will have approximately 5-7 minutes to present their poster, including Q&A. The judges may ask questions during the evaluation of your presentation. This is an opportunity for young scientists to learn about the latest findings from their peers in order to improve their skills as interdisciplinary researchers. The poster display is in hard copy format and is 1m x 1m long.

For more information on poster presentations and judging criteria, please refer to the Poster Presentation Guidelines.

Webinar: Webinar presentations are intended for interested participants who are unable to attend in person due to scheduling conflicts or other commitments. This option allows the presenter to record the presentation and present it in the webinar presentation session.

E-Poster: An e-Poster is also similar to a webinar presentation. At this session, presentations will be posted in poster form on the conference website, and speaker abstracts will be published in conference memorabilia and journals with DOIs.

Exhibition: At Infectious Diseases-2023, you will have the opportunity to showcase products and services from commercial and non-profit organizations such as pharmaceutical manufacturers, clinical trial facilities, management consultants, chemists, pharmacists, business representatives, and device manufacturers.

It is hereby reiterated that the 2023 Organizing Committee for Communicable Diseases is not authorized to assist with visa application operations. You may be asked to submit an invitation, acceptance letter, and payment receipt for registration to the Embassy.

Letter of Invitation: The letter of invitation certifies that the paper submission and application for registration have been received by the Board of Directors of the Conference Committee. It is provided in English and may be useful for visa applications.

Token Amount: You can pay a token amount of $150 and the payment receipt will act as proof of payment and help with your VISA application.

**If the application is denied, the 2023 Organizing Committee for Communicable Diseases cannot change the State Department's decision. Nor will we contact or consult with the Department of State or the Embassy on your behalf. If an individual's visa application is denied and proof of visa refusal must be provided, the registration fee will be refunded**